Phototherapy for scleroderma: Biologic rationale, results, and promise

Gary J. Fisher, Sewon Kang

Research output: Contribution to journalReview articlepeer-review


Scleroderma is a chronic disease of connective tissue characterized by deposition of large amounts of collagen. Localized scleroderma affects only the skin, whereas systemic disease, systemic sclerosis, may affect the lungs, gastrointestinal tract, kidneys, and heart in addition to the skin. Although the various forms of localized scleroderma are not life threatening, they result in considerable morbidity owing to joint contracture, loss of flexibility, and disfigurement. Although many different treatments have been attempted, until now none has proven to be effective. Accumulating evidence indicates that UVA irradiation offers a genuine opportunity to ameliorate localized scleroderma and the cutaneous manifestations of systemic sclerosis.

Original languageEnglish (US)
Pages (from-to)723-726
Number of pages4
JournalCurrent opinion in rheumatology
Issue number6
StatePublished - Nov 2002
Externally publishedYes

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Phototherapy for scleroderma: Biologic rationale, results, and promise'. Together they form a unique fingerprint.

Cite this